The Venture Codex Logo

The Venture Codex

Overview

Independent institute translating cancer research into clinical practice.

Deals · 12mo

2

Stage focus

Seed
Series A

Geographic focus

The Netherlands

Sector focus

—

Investment portfolio

3rounds
NAMEDATESIZE
Laigo Bio
Mar 2026Participated
$19 MSeed
Laigo Bio
Dec 2025Participated
$13 MSeed
Flindr Therapeutics
Apr 2024Participated
$21 MSeries A
Laigo Bio
Mar 2026Participated
$19 MSeed
Laigo Bio
Dec 2025Participated
$13 MSeed
Flindr Therapeutics
Apr 2024Participated
$21 MSeries A
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Oncode Oncology Bridge Fund: 3 funding rounds are recorded in the selected participation categories.All available history.
Oncode Oncology Bridge Fund: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed02
Series A01

Monthly Deal Activity

Oncode Oncology Bridge Fund: 3 deals are recorded across 31 months.All available history.
Oncode Oncology Bridge Fund: 3 deals are recorded across 31 months. All available history
MonthDeals
Apr '241
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Oncode Oncology Bridge Fund: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Oncode Oncology Bridge Fund: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3

Deal Size Distribution

Oncode Oncology Bridge Fund: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Oncode Oncology Bridge Fund: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M3
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Oncode Oncology Bridge Fund: Europe has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Oncode Oncology Bridge Fund: Europe has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Europe3
Oncode Oncology Bridge Fund: 14 co-investors are shown, with Curie Capital sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Oncode Oncology Bridge Fund: 14 co-investors are shown, with Curie Capital sharing 3 recorded deals. All available history
Co-investorShared deals
Curie Capital3
Angelini Ventures2
ArgoBio2
Cancer Research Horizons2
Eurazeo2
Kurma Partners2
ROM Utrecht Region2
Biovance Capital1
BOM1
Flanders Future Tech Fund1
Johnson & Johnson Innovation1
Qbic1
Swanbridge Capital1
V-Bio Ventures1

Investment Strategy

Oncode Oncology Bridge Fund: Led accounts for 0% and participating for 100% of round participation.All available history.
Oncode Oncology Bridge Fund: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating3100%
Oncode Oncology Bridge Fund: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Oncode Oncology Bridge Fund: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Emil Pot

Co-Founder and CEO

René Kuijten

Vice Chairman Supervisory Board, Initiator, Founder